63 related articles for article (PubMed ID: 36676722)
1. Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.
Huegel J; Mundy C; Sgariglia F; Nygren P; Billings PC; Yamaguchi Y; Koyama E; Pacifici M
Dev Biol; 2013 May; 377(1):100-12. PubMed ID: 23458899
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses.
Matsumoto K; Irie F; Mackem S; Yamaguchi Y
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10932-7. PubMed ID: 20534475
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier.
Khalil R; Boels MGS; ; van den Berg BM; Bruijn JA; Rabelink TJ; Hogendoorn PCW; Baelde HJ
Mol Genet Genomics; 2022 Mar; 297(2):397-405. PubMed ID: 35103870
[TBL] [Abstract][Full Text] [Related]
4. Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses.
Huegel J; Enomoto-Iwamoto M; Sgariglia F; Koyama E; Pacifici M
Am J Pathol; 2015 Jun; 185(6):1676-85. PubMed ID: 25863260
[TBL] [Abstract][Full Text] [Related]
5. Novel exostosin-2 mutation identified in a Chinese family with hereditary multiple osteochondroma.
Ruan W; Cao L; Chen Z; Kong M; Bi Q
Oncol Lett; 2018 Apr; 15(4):4383-4389. PubMed ID: 29541207
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for heparan sulfate co-polymerase action by the EXT1-2 complex.
Li H; Chapla D; Amos RA; Ramiah A; Moremen KW; Li H
Nat Chem Biol; 2023 May; 19(5):565-574. PubMed ID: 36593275
[TBL] [Abstract][Full Text] [Related]
7. Exostoisns (EXT1/2) in Head and Neck Cancers: An In Silico Analysis and Clinical Correlates.
Wang Y; Huang Y; Zhu H; Guo Z; Cheng J; Zhang C; Zhong M
Int Dent J; 2024 Jun; 74(3):446-453. PubMed ID: 37989698
[TBL] [Abstract][Full Text] [Related]
8. Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.
Veraldi N; Parra A; Urso E; Cosentino C; Locatelli M; Corsini S; Pedrini E; Naggi A; Bisio A; Sangiorgi L
Molecules; 2018 Dec; 23(12):. PubMed ID: 30544937
[TBL] [Abstract][Full Text] [Related]
9.
Wang Y; Zhong L; Xu Y; Ding L; Ji Y; Schutz S; Férec C; Cooper DN; Xu C; Chen JM; Luo Y
Front Genet; 2020; 11():607838. PubMed ID: 33414810
[TBL] [Abstract][Full Text] [Related]
10. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
Pacifici M
Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
[TBL] [Abstract][Full Text] [Related]
11. Hereditary multiple exostoses and heparan sulfate polymerization.
Zak BM; Crawford BE; Esko JD
Biochim Biophys Acta; 2002 Dec; 1573(3):346-55. PubMed ID: 12417417
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of EXT1 and Heparan Sulphate Deficiency Associated with Hereditary Multiple Exostoses in a Pakistani Family.
Ajmal M; Muhammad H; Nasir M; Shoaib M; Malik SA; Ullah I
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676722
[No Abstract] [Full Text] [Related]
13. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
[TBL] [Abstract][Full Text] [Related]
14. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
15. A splice mutation and mRNA decay of EXT2 provoke hereditary multiple exostoses.
Tian C; Yan R; Wen S; Li X; Li T; Cai Z; Li X; Du H; Chen H
PLoS One; 2014; 9(4):e94848. PubMed ID: 24728384
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
